Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom

被引：123

作者：

Gould, F. Kate ^{[1
]}

Brindle, Richard ^{[2
]}

Chadwick, Paul R. ^{[3
]}

Fraise, Adam P. ^{[4
]}

Hill, Simon ^{[5
]}

Nathwani, Dilip ^{[6
]}

Ridgway, Geoff L. ^{[7
]}

Spry, Michael J. ^{[1
]}

Warren, Rod E. ^{[8
]}

机构：

[1] Freeman Rd Hosp, Dept Microbiol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England

[2] Queen Alexandra Hosp, Dept Microbiol, Portsmouth PO6 3LY, Hants, England

[3] Salford Royal Hosp, Dept Microbiol, Salford M6 8HD, Lancs, England

[4] City Hosp NHS Trust, Dept Med Microbiol, Birmingham B18 7QH, W Midlands, England

[5] Poole Hosp, Dept Microbiol, Poole BH15 2JB, Dorset, England

[6] Univ Dundee, Ninewells Hosp & Med Sch, Infect Unit, Dundee DD1 9SY, Scotland

[7] Dept Hlth, London SE1 8UG, England

[8] Royal Shrewsbury Hosp, Dept Microbiol, Shrewsbury SY3 8XQ, Salop, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2009年 / 63卷 / 05期

关键词：

update; evidence-based guidelines; meticillin; new antistaphylococcal agents; UK; CRITICALLY-ILL PATIENTS; RISK-FACTORS; REDUCED SUSCEPTIBILITY; ENTEROCOCCUS-FAECIUM; ANTIMICROBIAL USE; COMPLICATED SKIN; INHIBITORY CONCENTRATION; NOSOCOMIAL TRANSMISSION; ANTIBIOTIC-TREATMENT; ENTERAL VANCOMYCIN;

D O I：

10.1093/jac/dkp065

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

These evidence-based guidelines are an updated version of those published in 2006. They have been produced after a literature review of the treatment and prophylaxis of methicillin-resistant Staphylococcus aureus (MRSA). The guidelines aim to complement those recently published for the antibiotic treatment of common and emerging community-onset MRSA infections in the UK. The guidelines have reviewed and updated, where appropriate, previous recommendations, taking into account any changes in the UK epidemiology of MRSA, ongoing national surveillance data and the value of new antistaphylococcal agents licensed for use in UK practice. Emerging therapies that have not been licensed for UK use are not reviewed, but their future potential role has been mentioned where deemed appropriate. Recommendations are given for the treatment of common infections caused by MRSA, elimination of MRSA from carriage sites and prophylaxis of surgical site infection.

引用

页码：849 / 861

页数：13

共 132 条

[11] Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage [J].

Bonora, MG ;

Solbiati, M ;

Stepan, E ;

Zorzi, A ;

Luzzani, A ;

Catania, MR ;

Fontana, R .

JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (03) :1153-1155

[12]

Boyce J M, 1989, Infect Dis Clin North Am, V3, P901

[13] Understanding and controlling methicillin-resistant Staphylococcus aureus infections [J].

Boyce, JM .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002, 23 (09) :485-487

[14] Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA [J].

Calfee, DP ;

Durbin, LJ ;

Germanson, TR ;

Toney, DM ;

Smith, EB ;

Farr, BM .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (06) :422-426

[15] Epidemiology of hospital-acquired infections in cirrhotic patients:: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis [J].

Campillo, B ;

Dupeyron, C ;

Richardet, JP .

EPIDEMIOLOGY AND INFECTION, 2001, 127 (03) :443-450

[16] Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals [J].

Cartolano, GL ;

Cheron, M ;

Benabid, D ;

Leneveu, M ;

Boisivon, A .

CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (05) :448-451

[17] Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus [J].

Cenizal, Mary Jo ;

Skiest, Daniel ;

Luber, Samuel ;

Bedimo, Roger ;

Davis, Pat ;

Fox, Patrick ;

Delaney, Kathleen ;

Hardy, R. Doug .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) :2628-2630

[18] Staphylococcus aureus bacteremia -: Recurrence and the impact of antibiotic treatment in a prospective multicenter study [J].

Chang, FY ;

Peacock, JE ;

Musher, DM ;

Triplett, P ;

MacDonald, BB ;

Mylotte, JM ;

O'Donnell, A ;

Wagener, MM ;

Yu, VL .

MEDICINE, 2003, 82 (05) :333-339

[19] Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene [J].

Chang, S ;

Sievert, DM ;

Hageman, JC ;

Boulton, ML ;

Tenover, FC ;

Downes, FP ;

Shah, S ;

Rudrik, JT ;

Pupp, GR ;

Brown, WJ ;

Cardo, D ;

Fridkin, SK .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1342-1347

[20] Comparison of Tn1546-like elements in vancomycin-resistant Staphylococcus aureus isolates from Michigan and Pennsylvania [J].

Clark, NC ;

Weigel, LM ;

Patel, JB ;

Tenover, FC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (01) :470-472

← 1 2 3 4 5 6 7 8 9 10 →